BioLineRx (BLRX) Change in Receivables (2014 - 2026)
BioLineRx (BLRX) posted quarterly Change in Receivables of -$46000.0 for Q4 2025, down 104.05% year-over-year from $1.1 million in Q4 2024, and down 158.97% quarter-over-quarter from $78000.0 in Q3 2025.
Powered by 
Analysis
BioLineRx (BLRX) Change in Receivables (2014 - 2026) Analysis & Trends
BioLineRx's Change in Receivables history runs 4 years deep, the most recent figure standing at -$46000.0 for Q4 2025.
- In Q4 2025, Change in Receivables fell 104.05% year-over-year to -$46000.0; the TTM figure through Dec 2025 stood at $2.4 million (up 214.73% YoY), while the FY2025 annual figure was $2.4 million, up 214.73% from the prior year.
- Change in Receivables for Q4 2025 stood at -$46000.0, down from $78000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.4 million in Q2 2025, with the low at -$2.5 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 37.16 Mn |
| 10 | BioLineRx | 6.46 Bn | 6.46 Bn | 235,000.00 | -46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | -432,000.00 |
| Jun 30, 2024 | -347,000.00 |
| Mar 31, 2024 | -2.47 Mn |
| Dec 31, 2015 | 658,000.00 |
| Sep 30, 2015 | -275,000.00 |
| Jun 30, 2015 | 34,000.00 |
| Mar 31, 2015 | -459,000.00 |
| Dec 31, 2014 | -285,000.00 |
| Sep 30, 2014 | 436,000.00 |
| Jun 30, 2014 | -193,000.00 |
| Mar 31, 2014 | 122,000.00 |